Bactrian camels shed large quantities of Middle East respiratory syndrome coronavirus (MERS-CoV) after experimental infection*

Dromedary camels play a significant part in the circulation and the zoonotic transmission of Middle East respiratory syndrome coronavirus (MERS-CoV). Researchers demonstrated that Bactrian camels are also susceptible to MERS-CoV infection and shed large quantities of infectious virus in nasal secretions. 

Comparative Analysis of Eleven Healthcare-Associated Outbreaks of Middle East Respiratory Syndrome Coronavirus (Mers-Cov) from 2015 to 2017

Researchers analyzed epidemiologic and clinical data of laboratory-confirmed Middle East respiratory syndrome coronavirus (MERS-CoV) cases from eleven healthcare-associated outbreaks in Saudi Arabia and the South Korea between 2015–2017.

MERS-CoV infection among healthcare workers and risk factors for death: Retrospective analysis of all laboratory-confirmed cases reported to WHO from 2012 to 2 June 2018

About 50 percent of reported laboratory-confirmed infections of Middle East respiratory syndrome coronavirus (MERS-CoV) have occurred in healthcare settings, with healthcare workers constituting over a third of all secondary infections.

Risk Factors for MERS-CoV Seropositivity among Animal Market and Slaughterhouse Workers, Abu Dhabi, United Arab Emirates, 2014–2017

The study investigated risk factors for Middle East respiratory syndrome (MERS) seropositivity in animal market and slaughterhouse workers at a site previously associated with zoonotic transmission of MERS. Given the large number of camels present, including many young camels, and the mixing of camels from multiple sources, this site probably facilitates MERS transmission among camels. Results demonstrated a relatively high MERS seroprevalence in workers at this site, ranging from six percent to 19 percent at each round across all occupations. 

Researchers develop new vaccine against deadly Middle East Respiratory Syndrome

Researchers made two versions of a potential vaccine and evaluated their effectiveness and safety in mice that were genetically altered to have more human-like immune responses. After the mice were vaccinated and then infected with Middle East respiratory syndrome (MERS), both vaccines protected the mice against clinical signs of disease and death.